Stay updated on Daratumumab Escalation Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Escalation Clinical Trial page.

Latest updates to the Daratumumab Escalation Clinical Trial page
- Check5 days agoChange DetectedThe history section now shows a new Revision: v3.3.3 entry, and the HHS Vulnerability Disclosure item and Revision: v3.3.2 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision v3.3.2 was added and revision v3.2.0 was removed from the history.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the site-wide notice about government funding status that warned users about potential delays in updates and processing. The change does not affect trial data, status, or results on the page.SummaryDifference0.7%

- Check55 days agoChange DetectedThe Record History shows several versions updating the study status, recruitment status, and key trial details (eligibility, arms/interventions, and outcomes). These changes reflect ongoing updates to the trial record.SummaryDifference0.1%

- Check84 days agoChange DetectedMajor update: add a government funding notice impacting data/transactions and mark a new version (v3.2.0); remove the old v3.1.0.SummaryDifference12%

- Check91 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.3%

Stay in the know with updates to Daratumumab Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Escalation Clinical Trial page.